Glycomimetics share price today

(GLYC)

Glycomimetics share price is $0.23 & ₹19.54 as on 21 Dec 2024, 2.30 'hrs' IST

$0.23

▲

0.03

(13.82%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Glycomimetics share price in Dollar and Rupees. Guide to invest in Glycomimetics from India. Also see the sentimental analysis on Indian investors investing in Glycomimetics. Get details on the Indian mutual funds that are investing in Glycomimetics. Get Analyst recommendations and forecasts along with all the Glycomimetics's financials.

Glycomimetics share price movements

Today's Low: $0.21
Today's High: $0.25
$0.23
10.0%
Downside
Day's Volatility :15.82%
Upside
6.47%
52 Weeks Low: $0.14
52 Weeks High: $3.53
$0.23
38.87%
Downside
52 Weeks Volatility :96.02%
Upside
93.48%

Glycomimetics Returns

Period	Glycomimetics Inc	Index (Russel 2000)
3 Months	42.19%	0.0%
6 Months	-12.27%	0.0%
1 Year	-90.79%	0.0%
3 Years	-84.91%	-19.7%

Glycomimetics Key Statistics

in dollars & INR

Previous Close	$0.2055
Open	$0.2
Today's High	$0.2459
Today's Low	$0.207
Market Capitalization	$15.1M
Today's Volume	$1.0M
52 Week High	$3.5299
52 Week Low	$0.1406
Revenue TTM	$10.0K
EBITDA	$-40.8M
Earnings Per Share (EPS)	$-0.62
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-104.49%

How to invest in Glycomimetics from India?

It is very easy for Indian residents to invest directly in Glycomimetics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Glycomimetics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Glycomimetics or GLYC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Glycomimetics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Glycomimetics shares which would translate to 3.695 fractional shares of Glycomimetics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Glycomimetics, in just a few clicks!

Returns in Glycomimetics for Indian investors in Rupees

Investment Value

₹1,00,000

Glycomimetics investment value today

Current value as on today

₹1,93,141

Returns

₹93,141

(+93.14%)

Returns from Glycomimetics Stock

₹90,945 (false-90.94%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Glycomimetics

-92%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Glycomimetics on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -92% less investors are searching Glycomimetics in the last 30 days versus the previous period.

Global Institutional Holdings in Glycomimetics

Bvf Inc
14.80%
Vanguard Group Inc
4.14%
Renaissance Technologies Corp
1.21%
BlackRock Inc
1.12%
Geode Capital Management, LLC
0.81%
Two Sigma Advisers, LLC
0.39%

Analyst Recommendation on Glycomimetics

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Glycomimetics(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Glycomimetics

What analysts predicted

Upside of 334.78%

Current:

$0.23

Target:

$1.00

Insights on Glycomimetics

Price Movement
In the last 1 month, GLYC stock has moved down by -26.9%
GLYC vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 124.5%
GLYC vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 108.1%

Glycomimetics Technicals Summary

Sell

Neutral

Buy

Glycomimetics is currently in a neutral trading position according to technical analysis indicators.

Glycomimetics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Glycomimetics Inc	-26.91%	-12.27%	-90.79%	-84.91%	-95.76%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.11%	13.66%	87.56%
Biontech Se	4.48%	30.56%	7.36%	-56.46%	225.6%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.49%	30.99%	109.19%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-1.97%	78.33%	80.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Glycomimetics Inc	NA	NA	0.0	0.0	-1.04	-0.59	NA	0.6
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Glycomimetics Inc	Buy	$15.1M	-95.76%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.56%	17.51	33.61%
Biontech Se	Buy	$26.7B	225.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	109.19%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.59%	32.84	-4.51%

About Glycomimetics

at glycomimetics, we are committed to helping to make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. our mission is to continue to advance our research and clinical candidates, providing hope for patients as we strive for tomorrow’s breakthrough treatments. glycomimetics is a clinical-stage biotechnology company. we use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. since the company’s inception in 2003, we have developed a robust, diversified product pipeline. we are a public company traded on the nasdaq under the symbol glyc.

Organization	Glycomimetics
Employees	35
CEO	Mr. Harout Semerjian
Industry	Health Technology

Management People of Glycomimetics

Name	Title
Mr. Harout Semerjian	CEO, President & Director
Ms. Rachel K. King	Co-Founder & Director
Mr. Brian M. Hahn	Senior VP & CFO
Ms. Stephanie R. Irish CPA	Vice President of Accounting
Mr. Christian B. Dinneen-Long	General Counsel & Company Secretary
Mr. Bruce Johnson	Senior VP & Chief Commercial Officer
Mr. Chinmaya Rath	Senior VP & Chief Business Officer
Mr. Shantha Tyavanagimatt Ph.D.	Senior Vice President of Technical Operations

Important FAQs about investing in Glycomimetics from India :

What is Glycomimetics share price today?

Glycomimetics share price today stands at $0.23, Open: $0.20 ; Previous Close: $0.21 ; High: $0.25 ; Low: $0.21 ; 52 Week High: $3.53 ; 52 Week Low: $0.14. The stock opens at $0.20, after a previous close of $0.21. The stock reached a daily high of $0.25 and a low of $0.21, with a 52-week high of $3.53 and a 52-week low of $0.14.

Can Indians buy Glycomimetics shares?

Yes, Indians can invest in the Glycomimetics (GLYC) from India.

With INDmoney, you can buy Glycomimetics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Glycomimetics at zero transaction cost.

How can I buy Glycomimetics shares from India?

It is very easy to buy Glycomimetics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Glycomimetics be purchased?

Yes, you can buy fractional shares of Glycomimetics with INDmoney app.

What are the documents required to start investing in Glycomimetics stocks?

To start investing in Glycomimetics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.